ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Study Links Native American Ancestry to Leukemia Relapse

February 25, 2011

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

OMB Specifies One Year Only Funding for 200 grants Under Supplemental Appropriations Level of 6,200

September 6, 1985

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977

What Would You Tell a 45-Year-Old? Waxman Asks Broder

February 4, 1994

In Brief: Former HHS Official Could Replace Heckler, Reagan Signs Federal Cigarette Tax Extension

October 11, 1985